Get the Stockscreener App
0.00
100.00%
-1.27
Igm Biosciences Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
See More
Previous Close:
$1.27
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$76.57M
Revenue:
$2.91M
Net Income/Loss:
$-220.40M
P/E Ratio:
0.00
EPS:
-3.64
Net Cash Flow:
$-176.15M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$1.31
52-Week Range:
$0.00
$22.50
Igm Biosciences Inc Stock (IGMS) Company Profile
Name
Igm Biosciences Inc
Sector
Industry
Phone
650-965-7873
Address
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
Compare IGMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
0.00 | 76.57M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.52 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.10 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.52 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.81 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
319.63 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-10-25 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-10-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-10-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-10-25 | Downgrade | Stifel | Buy → Hold |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Oct-01-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-24 | Downgrade | Truist | Buy → Hold |
| Feb-09-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-15-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-07-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-09-22 | Resumed | Jefferies | Buy |
| Oct-17-22 | Initiated | JP Morgan | Neutral |
| Aug-29-22 | Initiated | BofA Securities | Buy |
| Dec-13-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-05-21 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-26-21 | Initiated | Morgan Stanley | Overweight |
| Jan-29-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-19-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-22-20 | Downgrade | Wedbush | Outperform → Neutral |
| Jul-17-20 | Initiated | Robert W. Baird | Outperform |
| Jul-01-20 | Initiated | H.C. Wainwright | Buy |
| May-28-20 | Initiated | SunTrust | Buy |
| Apr-22-20 | Initiated | Wedbush | Outperform |
| Oct-14-19 | Initiated | Guggenheim | Buy |
| Oct-14-19 | Initiated | Jefferies | Buy |
| Oct-14-19 | Initiated | Piper Jaffray | Overweight |
| Oct-14-19 | Initiated | Stifel | Buy |
View All
Igm Biosciences Inc Stock (IGMS) Latest News
Is IGM Biosciences Inc. stock showing strong momentumEarnings Growth Report & Fast Gain Stock Trading Tips - newsyoung.net
What makes IGM Biosciences Inc. stock price move sharplyJuly 2025 Price Swings & Growth Oriented Trading Recommendations - thegnnews.com
IGM Biosciences, Inc. (NASDAQ:IGMS) Given Average Rating of "Reduce" by Analysts - MarketBeat
IGM Biosciences, Inc.(NasdaqGS: IGMS) dropped from S&P TMI Index - MarketScreener
Advanced analytics toolkit walkthrough for IGM Biosciences Inc.Earnings Summary Report & AI Forecast Swing Trade Picks - Newser
Quantitative breakdown of IGM Biosciences Inc. recent moveMarket Rally & Weekly Breakout Opportunity Watchlist - Newser
What institutional flow reveals about IGM Biosciences Inc.2025 Breakouts & Breakdowns & Weekly Breakout Opportunity Watchlist - Newser
IGM Biosciences Inc.’s Beta Climbs After Market VolatilityProven Entry Plan With Low Risk Shared - beatles.ru
Is IGM Biosciences Inc. stock a hidden gemPotential 10x Return Stocks - sisaissue.com
IGM Biosciences (IGMS) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Is IGM Biosciences Inc. stock a top performer YTDGolden Triangle Formation Screener - thegnnews.com
IGM Biosciences earnings beat by $1.70, revenue topped estimates - Investing.com Canada
IGM Biosciences (NASDAQ:IGMS) Releases Quarterly Earnings Results, Beats Estimates By $1.88 EPS - MarketBeat
IGM Biosciences Inc. Stock Recovery Path — Analyst BreakdownPortfolio Diversification Stock Ideas From Experts - beatles.ru
What are analysts’ price targets for IGM Biosciences Inc. in the next 12 monthsGet exclusive market insights for better trading - Jammu Links News
How strong is IGM Biosciences Inc. company’s balance sheetUnlock exclusive trading strategies - Jammu Links News
Is IGM Biosciences Inc. a good long term investmentGet exclusive access to expert stock recommendations - Jammu Links News
How does IGM Biosciences Inc. compare to its industry peersMaximize portfolio value with timely trades - Jammu Links News
Is it the right time to buy IGM Biosciences Inc. stockMaximize gains with expert analysis - Jammu Links News
When is IGM Biosciences Inc. stock expected to show significant growthFind market-beating stocks for your portfolio - Jammu Links News
What is the risk reward ratio of investing in IGM Biosciences Inc. stockBuild a diversified portfolio for sustainable growth - Jammu Links News
What catalysts could drive IGM Biosciences Inc. stock higher in 2025Access daily stock market expert updates - Jammu Links News
How many analysts rate IGM Biosciences Inc. as a “Buy”Get timely alerts on top-performing stocks - Jammu Links News
Chart based exit strategy for IGM Biosciences Inc.High Probability Trade Outcome Prediction - Newser
Sentiment Tools Show Shift in Trader Mood on IGM Biosciences Inc.Earnings Play Trade Plan With Alerts Shared - metal.it
IGM Biosciences 2025 Q2 Earnings Strong Performance as Net Income Swings 303.7% - AInvest
Is IGM Biosciences Inc. a candidate for recovery playScalable Strategy with Chart Confirmation - Newser
Custom watchlist performance reports with IGM Biosciences Inc.High Return Trade Roadmap with Setup Filters - Newser
IGM Biosciences Q2 2025 Earnings Report: Persistent Losses Amid Weak Earnings Beat Performance - AInvest
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates - sharewise.com
IGM Biosciences Surpasses Earnings and Revenue Estimates in Q2, Shares Down 79.4% YTD - AInvest
How does IGM Biosciences Inc. generate profit in a changing economyFree Stock Alerts For Every Investor - Jammu Links News
IGM Biosciences Q2 2025 Earnings Miss: A Harbinger of Persistent Pressure - AInvest
IGM Biosciences Inc. stock daily chart insightsAlpha Stock Picks with Chart Confirmation - Newser
Competitive Positioning of IGM Biosciences Inc.: Is It Leading or LaggingFree Oversold Bounce Stock Play Ideas - Newser
Why IGM Biosciences Inc. stock attracts strong analyst attentionFree Consistent Income Focused Trade List - Newser
Multi factor analysis applied to IGM Biosciences Inc.Predictable Return Plan with Entry Guidance - Newser
Key metrics from IGM Biosciences Inc.’s quarterly dataShort-Term Trade Setup with Forecast Insight - Newser
Volume spikes in IGM Biosciences Inc. stock – what they meanFree Low Risk Picks for Daily Trading - Newser
Predicting IGM Biosciences Inc. trend using moving averagesDeep Learning Stock Forecast for Investors - Newser
Mary Beth Harler Sells 14,501 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) Stock - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) CFO Misbah Tahir Sells 8,741 Shares - MarketBeat
Will IGM Biosciences Inc. Recover After Recent DeclineCapital Growth With Controlled Risk Picks Suggested - metal.it
Is IGM Biosciences Inc. a growth stock or a value stockCapitalize on market trends with confidence - jammulinksnews.com
Igm Biosciences Inc Stock (IGMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):